| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 6.85▲ | 6.85▲ | 6.86▲ | 7.50▼ | 6.73▲ |
| MA10 | 6.85▲ | 6.90▲ | 7.05▼ | 7.57▼ | 6.86▲ |
| MA20 | 6.84▲ | 7.05▼ | 7.25▼ | 6.94▼ | 6.40▲ |
| MA50 | 6.88▲ | 7.42▼ | 7.68▼ | 6.94▼ | 5.10▲ |
| MA100 | 7.04▼ | 7.73▼ | 7.20▼ | 6.46▲ | 5.57▲ |
| MA200 | 7.20▼ | 7.11▼ | 7.01▼ | 5.43▲ | 7.61▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.007▲ | 0.002▲ | -0.036▼ | 0.023▲ | -0.003▼ |
| RSI | 56.356▲ | 38.062▼ | 34.889▼ | 47.755▼ | 55.207▲ |
| STOCH | 45.147 | 14.290▼ | 7.489▼ | 53.105 | 43.560 |
| WILL %R | 0.000▲ | -82.645▼ | -84.211▼ | -63.898 | -50.000 |
| CCI | 139.048▲ | -60.750 | -90.136 | -15.738 | 71.156 |
|
Thursday, February 26, 2026 08:07 AM
The first psilocybin compound to achieve two positive Phase 3 results in treatment-resistant depression cleared ...
|
|
Thursday, February 26, 2026 03:56 AM
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the exercise of 35,059,448 warrants, which were ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 27/02/26 | 7.34 | 7.427 | 6.79 | 6.90 | 4,106,975 |
| 26/02/26 | 7.33 | 7.49 | 6.985 | 7.33 | 3,962,855 |
| 25/02/26 | 8.07 | 8.095 | 7.23 | 7.44 | 4,880,688 |
| 24/02/26 | 7.90 | 8.03 | 7.63 | 7.99 | 2,698,253 |
| 23/02/26 | 8.10 | 8.10 | 7.49 | 7.85 | 3,902,385 |
| 20/02/26 | 8.23 | 8.40 | 7.95 | 8.05 | 3,861,958 |
| 19/02/26 | 8.51 | 8.52 | 7.71 | 8.26 | 14,674,389 |
| 18/02/26 | 8.26 | 8.90 | 7.94 | 8.45 | 8,778,844 |
| 17/02/26 | 7.83 | 8.7951 | 7.31 | 7.63 | 34,832,649 |
| 13/02/26 | 5.89 | 6.05 | 5.77 | 5.81 | 906,630 |
|
|
||||
|
|
||||
|
|